Business
Nanox Receives FDA 510(k) Clearance for TAP2D New Image Enhancement Capability for Nanox.ARC and Nanox.ARC X Systems
This clearance enables the next phase of development aimed ultimately at removing the adjunct use in the US The newly cleared capability provides radiologists with a 2D image generated directly from the tomosynthesis scan, enabling both 3D and 2D views from a single scan, without exposing the patient to any additional radiation PETACH TIKVA, Israel – February 3 – NANO-X IMAGING LTD (“Nanox” or the “Company”) today announced that the United States Food and Drug Administration (FDA) has granted 51
About this update from Nano-x Imaging Ltd
[{"type":"image","alt":"NANO-X IMAGING LTD","displaySize":"","headline":null,"caption":"NANO-X IMAGING LTD","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":77,"url":"https://media.zenfs.com/en/globenewswire.com/da574cbd2a09fd59f8e7f098b54f9885"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/4qRrEIqR0bdckgiFNh_3FA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwODtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/da574cbd2a09fd59f8e7f098b54f9885","width":300,"height":77}},"lazy":false},{"type":"text","content":"","length":0,"tagName":"p"},{"type":"text","content":"This clearance enables the next phase of development aimed ultimately at removing the adjunct use in the US","length":107,"tagName":"p"},{"type":"text","content":"The newly cleared capability provides radiologists with a 2D image generated directly from the tomosynthesis scan, enabling both 3D and 2D views from a single scan, without exposing the patient to any additional radiation","length":221,"tagName":"p"},{"type":"text","content":"PETACH TIKVA, Israel – February 3 – NANO-X IMAGING LTD (“Nanox” or the “Company”) today announced that the United States Food and Drug Administration (FDA) has granted 510(k) clearance for TAP2D, a new cloud enabled image enhancement capability for the Nanox.ARC and Nanox.ARC X digital tomosynthesis systems. This clearance marks an important step in Nanox's regulatory strategy to position its tomosynthesis systems as primary diagnostic solutions and advances the Company’s commitment to increased access to innovative medical imaging solutions.","length":552,"tagName":"p"},{"type":"text","content":"The newly cleared enhancement capability provides radiologists with an additional, clear 2D view, generated from the digital tomosynthesis scan. The feature is designed to support evaluation while maintaining a smooth workflow for users. The additional view is automatically delivered within the existing clinical environment without adding complexity for clinicians or operators.","length":380,"tagName":"p"},{"type":"text","content":"The Nanox.ARC and Nanox.ARC X are FDA cleared, multi-source digital tomosynthesis systems that utilize advanced 3D imaging technology to provide enhanced diagnostic capabilities at a lower cost and radiation dose than traditional systems.","length":238,"tagName":"p"},{"type":"text","content":"The Nanox.AR...